GSK plc files Form 13F; $599.15M holdings

GSK plc filed a Form 13F reporting institutional holdings.

Rhea-AI Filing Summary

GSK plc filed a Form 13F reporting institutional holdings. The report lists 13 reported positions with a Form 13F Information Table Value Total of $599,153,380. The filing was signed by Victoria Whyte as Authorised Signatory on 05-09-2026.

Key Figures

Form 13F Information Table Value Total: $599,153,380 Form 13F Information Table Entry Total: 13 positions Signature Date: 05-09-2026

3 metrics

Form 13F Information Table Value Total $599,153,380 Form 13F Summary Page

Form 13F Information Table Entry Total 13 positions Form 13F Summary Page

Signature Date 05-09-2026 Signed by Victoria Whyte, Authorised Signatory

Key Terms

Form 13F, Form 13F Information Table Value Total, Institutional Investment Manager

3 terms

Form 13F regulatory

"Form 13F Summary Page --------------------- | Report Summary"

A Form 13F is a quarterly filing that large investment managers must submit to disclose their holdings in publicly traded stocks and certain other securities. It acts like a peek into the portfolios of big investors, helping other market participants see what large players are buying or selling and offering clues about investment trends, crowded trades, and potential market impact.

Form 13F Information Table Value Total financial

"Form 13F Information Table Value Total: | 599,153,380"

Institutional Investment Manager regulatory

"Institutional Investment Manager Filing this Report Name: | GSK plc"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GSK's Form 13F filing show for total holdings?

The filing shows a total reported value of $599,153,380. This figure is the Form 13F Information Table Value Total and represents the market value of the 13 reported positions as disclosed in the report.

How many positions does GSK list in this 13F filing?

The report lists 13 positions. The Form 13F Information Table Entry Total is given as 13, indicating the number of distinct holdings reported by the institutional manager in this filing.

Who signed GSK's Form 13F and when was it signed?

The report was signed by Victoria Whyte. The signature line shows Victoria Whyte as Authorised Signatory for and on behalf of GSK plc, dated 05-09-2026 in London.

Does this Form 13F indicate trades or just holdings for GSK?

This Form 13F reports holdings rather than trades. Form 13F filings disclose securities holdings at the report date; they do not itemize transaction-level trade activity in this summary excerpt.

Where can investors find the detailed holdings from this GSK 13F?

Detailed holdings appear in the Form 13F Information Table. The summary indicates 13 entries and a total value of $599,153,380; the full table lists each security, which is part of the complete filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:45 PM EDT Learn about SEC filing dates

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 03-31-2026

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	GSK plc
Address:	79 NEW OXFORD STREET
	London, X0 WC1A 1DG
Form 13F File Number:	028-26280
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Victoria Whyte
Title:		Authorised Signatory for and on behalf of GSK plc
Phone:		44-77709-42658
Signature, Place, and Date of Signing:
/s/ Victoria Whyte			London, X0	05-09-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		13
	Form 13F Information Table Value Total:		599,153,380
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE